Stocktoria

Profusa, Inc. PFSA

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022
Financials
Revenue$100,000
Operating income-$27.7M-$4.5M-$1.5M-$1.3M
Net income-$35.8M-$9.2M$1.2M$7.2M
Operating cash flow-$16.2M-$2.1M-$2.1M-$581,189
Free cash flow-$16.3M
Total assets$3.8M$3.1M$10.9M$194.7M
Total liabilities$30.4M$57.1M$5.1M$1.8M
Shareholders' equity-$26.7M-$119.2M-$110.0M-$619,476
Ratios
Operating margin-4500.0%
Net margin-9230.0%
Return on assets-949.0%-300.4%10.7%3.7%
Return on equity134.4%7.7%-1.1%-1157.1%
Current ratio0.170.000.320.55

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001859807 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.